Electroporation had been instrumental in many different areas and new applications are being constantly developed.
Just last week, Medtronic received FDA approval to test electroporation as an ablation method for treatment of atrial fibrillation
(newsroom.medtronic.com/news-releases/news-release-details/medtronic-receives-fda-approval-trial-evaluating-new-energy).
The expectations are high, as described in the report from the AF Symposium (www.afsymposium.com) in this month’s Newsletter.